Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd (SHE:301130)

SHE:301130 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	251.61	255.25	225.14	255.4	285.14	284.79
Other Revenue	1.16	1.16	0.35	0.07	0.51	1.53
Revenue	252.77	256.41	225.49	255.47	285.66	286.32
Revenue Growth (YoY)	2.10%	13.71%	-11.73%	-10.57%	-0.23%	-11.88%
Cost of Revenue	60.01	61.16	45.52	47.42	46.98	44.32
Gross Profit	192.76	195.24	179.97	208.05	238.68	242
Selling, General & Admin	143.28	144.9	142.24	153.66	168.88	180.9
Research & Development	8.18	10.22	8.7	11.74	13.31	4.37
Other Operating Expenses	7.59	4.97	5.88	6.42	7.92	8.36
Operating Expenses	159.27	160.74	156.29	171.77	190.43	193.54
Operating Income	33.49	34.5	23.69	36.28	48.25	48.46
Interest Expense	-0.38	-0.07	-0.05	-	-	-
Interest & Investment Income	4.73	6.82	13.35	11.36	3.85	3.89
Other Non Operating Income (Expenses)	0.65	-0.06	-0.05	-0.01	-0.04	0.03
EBT Excluding Unusual Items	38.5	41.2	36.93	47.63	52.05	52.39
Gain (Loss) on Sale of Investments	0.17	0.74	3.15	1.17	-	-
Gain (Loss) on Sale of Assets	-0.5	-0.5	1.87	-	-	-0.02
Asset Writedown	0.4	-0	-0.17	-0	-0.17	-0
Other Unusual Items	5.14	5.08	16.53	1.64	7.32	6.56
Pretax Income	43.71	46.51	58.31	50.43	59.21	58.93
Income Tax Expense	6.16	6.25	7.81	9.71	7.19	9.18
Net Income	39.35	40.27	50.5	40.72	52.02	49.74
Net Income to Common	39.35	40.27	50.5	40.72	52.02	49.74
Net Income Growth	-9.07%	-20.26%	24.01%	-21.71%	4.58%	-8.92%
Shares Outstanding (Basic)	76	78	81	77	61	61
Shares Outstanding (Diluted)	76	78	81	77	61	61
Shares Change (YoY)	-3.07%	-3.66%	4.35%	27.78%	-0.00%	0.00%
EPS (Basic)	0.51	0.52	0.63	0.53	0.86	0.82
EPS (Diluted)	0.51	0.52	0.63	0.53	0.86	0.82
EPS Growth	-6.19%	-17.23%	18.84%	-38.73%	4.58%	-8.92%
Free Cash Flow	-15.79	-80.73	-68.79	12.83	37.83	50.03
Free Cash Flow Per Share	-0.21	-1.04	-0.85	0.17	0.62	0.83
Dividend Per Share	0.260	0.260	0.260	0.160	0.130	-
Dividend Growth	-	-	62.50%	23.08%	-	-
Gross Margin	76.26%	76.15%	79.81%	81.44%	83.55%	84.52%
Operating Margin	13.25%	13.46%	10.50%	14.20%	16.89%	16.93%
Profit Margin	15.57%	15.71%	22.40%	15.94%	18.21%	17.37%
Free Cash Flow Margin	-6.25%	-31.49%	-30.51%	5.02%	13.24%	17.47%
EBITDA	58.81	56.92	42.23	54.77	66.96	68.92
EBITDA Margin	23.27%	22.20%	18.73%	21.44%	23.44%	24.07%
D&A For EBITDA	25.32	22.42	18.55	18.49	18.71	20.46
EBIT	33.49	34.5	23.69	36.28	48.25	48.46
EBIT Margin	13.25%	13.46%	10.50%	14.20%	16.89%	16.93%
Effective Tax Rate	14.08%	13.43%	13.39%	19.25%	12.14%	15.59%
Revenue as Reported	252.77	256.41	225.49	255.47	285.66	286.32

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.